Cite
MLA Citation
Eileen M. O'Reilly et al.. “Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma.” Cancer, vol. 124, no. 7, 2018, pp. 1374–1382. http://access.bl.uk/ark:/81055/vdc_100057940108.0x000062